essential pro liposomal glutathione GSH® – Capsules and Liquid Liposomal Gluthathione Supplement

CagriSema's imminent approval will create true competition at the top of the obesity treatment landscape

Promotes tissue integrity Emerging research has examined BPC-157s potential to support healthy tissue function

Use reconstitution calculator

The preclinical research is not trivial, and legitimate questions about potential applications in tendon repair, gut healing, and neuroprotection merit serious investigation

Table 5: Changes from Week 26 Baseline to Week 52 in IGF-1, IGFBP-3, Weight, and Waist Circumference by Treatment Group (Intent-To-Treat Population with Last Observation Carried Forward) Patients treated with a 2 mg dose of EGRIFTA (1 mg/formulation) for 52 weeks (T-T group) showed no change between Weeks 26 and 52 in mean trunk fat (increase of 0.1 kg in Study 1 and decrease of 0.5 kg in Study 2, respectively, compared with an increase of 1.4 kg in patients in the T-P group in Study 1 and an increase of 1.09 kg in Study 2, respectively) nor was there a change from Week 26 baseline in mean lean body mass (decrease of 0.1 kg in Study 1 and increase of 0.1 kg in Study 2, respectively, compared with a decrease of 1.8 kg in patients in the T-P group in Study 1 and a decrease of 1.7 kg in Study 2, respectively)